Investigational Site Number : 4840009

Mexico City, Mexico City 04530

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Systemic Lupus Erythematosus

Studies at this site

• Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus — Running, not enrolling
• Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older — Stopped early